Abnormal circulating neutrophil linked matrix metalloproteinase –9 in stable coronary artery disease

Muzahir H. Tayebjee; Gregory Y. H. Lip; Kiat T. Tan; Robert J. MacFadyen

doi:10.1055/s-0037-1612586

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2006; 95(01): 202-204
DOI: 10.1055/s-0037-1612586

Letter to the Editor

Schattauer GmbH

Abnormal circulating neutrophil linked matrix metalloproteinase –9 in stable coronary artery disease

Muzahir H. Tayebjee

¹Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, United Kingdom

,

Gregory Y. H. Lip

¹Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, United Kingdom

,

Kiat T. Tan

¹Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, United Kingdom

,

Robert J. MacFadyen

¹Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, United Kingdom

› Author Affiliations

Abstract

Full Text

References

References
1 Kai H, Ikeda H, Yasukawa H. et al. Peripheral blood levels of matrix metalloproteases-2 and –9 are elevated in patients with acute coronary syndromes. J Am Coll Cardiol 1998; 32: 368-72.
2 Kalela A, Koivu T, Sisto T. et al. Serum matrix metalloproteinase-9 concentration in angiographically assessed coronary artery disease. Scand J Clin Lab Invest 2002; 65: 337-42.
3 Lindsey M, Wedin K, Brown M. et al. Matrix-dependent mechanism of neutrophil-mediated release and activation of matrix metalloproteinase 9 in myocardial ischemia/reperfusion. Circulation 2001; 103: 2181-7.
4 Tao Z, Cavasin M, Yang F. et al. Temporal change in matrix metalloproteinase expression and inflammatory response associated with cardiac rupture after myocardial infarcation in mice. Life Sci 2004; 74: 1561-72.
5 Lin TC, Li CY, Tsai CS. et al. Neutrophil-mediated secretion and activation of matrix metalloproteinase-9 during cardiac surgery with cardiopulmonary bypass. Anesth Analg 2005; 100: 1554-60.
6 Hamsten A, Walldius G, Szamosi A. et al. Relationship of angiographically defined coronary artery disease to serum lipoproteins and apolipoproteins in young survivors of myocardial infarction. Circulation 1986; 73: 1097-110.
7 Austen WG, Edwards JE, Frye RL. et al. A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975; 51 (Suppl. 04) 5-40.
8 Tayebjee MH, Lip GY, Tan KT. et al. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease. Am J Cardiol 2005; 96: 339-45.
9 Pugin J, Widmer M, Kossodo S. et al. Human neutrophils secrete gelatinase B in vitro and in vivo in response to endotoxin and proinflammatory mediators. Am J Respir Cell Mol Biol 1999; 20: 458-64.
10 Delclaux C, Delacourt C, D’Ortho M. et al. Role of gelatinase B and elastase in human polymorphonuclear neutrophil migration across basement membranes. Am J Respir Cell Mol Biol 1996; 14: 288-95.
11 Price B, Dennison C, Tschesche H. et al. Neutrophil tissue inhibitor of matrix metalloproteinases-1 occurs in novel vesicles that do not fuse with the phagosome. J Biol Chem 2000; 275: 28308-15.
12 Dollery C, Owen C, Sukhowa G. et al. Neutrophil elastase in human atherosclerotic plaque: production by macrophages. Circulation 2003; 107: 2829-36.
13 Cundall M, Sun Y, Miranda C. et al. Neutrophilderived matrix metalloproteinase-9 is increased in severe asthma and poorly inhibited by glucocorticoids. J Allergy and Clin Immunol 2003; 112: 1064-71.
14 Justicia C, Panes J, Sole S. et al. Neutrophil infiltration increases matrix metalloproteinase-9 in the ischemic brain after occlusion/reperfusion of the middle cerebral artery in rats. J Cereb Blood Flow Metab 2003; 23: 1430-40.
15 Romanic AM, Harrison SM, Bao W. et al. Myocardial protection from ischemia/reperfusion injury by targeted deletion of matrix metalloproteinase-9. Cardiovasc Res 2002; 54: 495-8.
16 Owen C, Hu Z, Barrick B. et al. Inducible expression of tissue inhibitor of metalloproteinases-resistant matrix metalloproteinase-9 on the cell surface of neutrophils. AmJ Respir Cell Mol Biol 2003; 29: 283-94.